Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Wajnberg, Ania, Amanat, Fatima, Firpo, Adolfo, Altman, Deena R., Bailey, Mark J., Mansour, Mayce, McMahon, Meagan, Meade, Philip +10 more·2020·Science
DOI 10.1126/science.abd7728

Cited by (1,007)

Items 901–1,000 of 1,007

  1. In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay
    Ágnes Kovács, Zoltán Hérincs, Krisztián Papp, Jakub Zbigniew Kaczmarek, Daniel Nyberg Larsen, Pernille Stage, László Bereczki, Eszter Újhelyi, Tamás Pfeil, József Prechl · 2025 · Frontiers in Immunology
  2. Dynamics of Crossed Acquired Immunity Against SARS‐CoV‐2 Variants: From Vaccine to Hybrid Immunity in China
    Hao Wang, Zhihao Zhang, Mengze Gan, Zhangbo Cui, Bihao Wu, Shuo Feng, Jun Xu, Jinge Cao, Yuying Wen, Zhen Wang et al. · 2025 · Journal of Medical Virology
  3. SARS-CoV-2 Serology Monitoring of a Cancer Center Staff in the Pandemic Most Infected Italian Region
    Chiara Maura Ciniselli, Arianna Micali, Loris De Cecco, Paola Notti, Valentina Sinno, Elena Luison, Cecilia C. Melani, Maria Grazia Daidone, Giovanni Apolone, Paolo Verderio et al. · 2021 · Cancers
  4. Clinician guide to COVID-19 diagnostics
    Mildred A. Iro, Helen Umpleby, Emanuela Pelosi · 2021 · Archives of Disease in Childhood Education & Practice
  5. Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses
    Alana F. Ogata, Roey Lazarovits, Augusta Uwamanzu‐Nna, Tal Gilboa, Chi‐An Cheng, David R. Walt · 2021 · Clinics in Laboratory Medicine
  6. Natural immune response and protection from SARS-CoV-2 reinfection
    Katia Margiotti, Marco Fabiani, Alvaro Mesoraca, Claudio Giorlandino · 2021 · Acta Virologica
  7. Receptor-binding domain–based immunoassays for serosurveillance differentiate efficiently between SARS-CoV2–exposed and non-exposed farmed mink
    Jorge Pulido, Marga García-Durán, Ricardo Fernández-Antonio, Carmen Galán, Lissette López, Carmen Vela, Ángel Venteo, Paloma Rueda, Luis Alfonso Rivas · 2021 · Journal of Veterinary Diagnostic Investigation
  8. Characterization of IgG Antibody Response against SARS-CoV-2 (COVID-19) in the Cypriot Population
    George Krashias, Elie Deeba, Astero Constantinou, Maria S. Hadjiagapiou, Dana Koptides, Jan Richter, Christina Tryfonos, Stavros Bashiardes, Anastasia Lambrianides, Maria A. Loizidou et al. · 2021 · Microorganisms
  9. Antibodies against SARS-CoV-2 after natural infection in healthcare workers and clinical characteristics as putative antibody production prediction
    Daniëlle A. T. Hanssen, John Penders, K. Heijgele, S. de Leede, Marlies Mulder, Leonie E. A. Bank, Michiel Slaats, Paul H. M. Savelkoul, Inge H. M. van Loo · 2022 · Journal of Clinical Virology Plus
  10. Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis
    Ersan Atahan, Buket Çalışkaner Öztürk, Rüveyda Akçin, Suat Sarıbaş, Bekir Sami Kocazeybek · 2022 · Balkan Medical Journal
  11. Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
    John Kimotho, Yiakon Sein, Shahin Sayed, Reena Shah, Kennedy Mwai, Mansoor Noorali Saleh, Perpetual Wanjiku, Jedidah K. Mwacharo, James Nyagwange, Henry Karanja et al. · 2023 · Wellcome Open Research
  12. Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada
    Leah J. Ricketson, Emily J. Doucette, Isabella Alatorre, Tarannum Tarannum, Joslyn Gray, William Booth, Graham A. Tipples, Carmen L. Charlton, Jamil N. Kanji, Kevin Fonseca et al. · 2024 · BMC Infectious Diseases
  13. Modular DNA barcoding of nanobodies enables multiplexed in situ protein imaging and high-throughput biomolecule detection
    Shilin Zhong, Ruiyu Wang, Xinwei Gao, Qingchun Guo, Rui Lin, Minmin Luo · 2025 · eLife
  14. Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19
    Aldo Barrera, Constanza Martínez-Valdebenito, Bruno Nervi, Aracelly Gaete-Argel, Nicolás M. S. Gálvez, Catalina Osses, Cecilia Vizcaya, María Elena Ceballos, Jaime I. Pereira, Mayling Chang et al. · 2025 · Current Research in Microbial Sciences
  15. Antibody repertoire associated with clinically diverse presentations of pediatric SARS-CoV-2 infection
    Natalie Bruiners, Rahul Ukey, Katherine C. Konvinse, Marlayna Harris, Müge Kalaycıoğlu, Jason H. Yang, Emily Yang, Usha Ganapathi, William J. Honnen, Tracy Andrews et al. · 2026 · Scientific Reports
  16. Approaching the Interpretation of Discordances in SARS-CoV-2 Testing
    Sandeep N. Wontakal, Robert H. Bortz, Wen-Hsuan Wendy Lin, Inessa Gendlina, Amy Sue Fox, Eldad A. Hod, Kartik Chandran, Michael B. Prystowsky, Louis M. Weiss, Steven L. Spitalnik · 2021 · Open Forum Infectious Diseases
  17. SARS-CoV-2 mechanisms of action and impact on human organism, risk factors and potential treatments. An exhaustive survey
    Belén Carro · 2021 · All Life
  18. Seroprevalence and dynamics of anti-SARS-CoV-2 antibody among healthcare workers following ChAdOx1 nCoV-19 vaccination
    Soma Sarkar, Shantanab Das, Kabita Choudhury, Saibal Mukherjee, Raghunath Chatterjee · 2022 · Epidemiology and Infection
  19. Longitudinal T Cell Responses against Ancestral, Delta, and Omicron SARS-CoV-2 Variants Determined by Rapid Cytokine Release Assay in Whole Blood
    Maria A Oliver, Rhys T. Meredith, Bryan R Smith, Max D. Bermingham, Nicole F. Brackett, Martin D. Chapman · 2022 · ImmunoHorizons
  20. Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol
    Eggi Arguni, Fatwa Sari Tetra Dewi, Jajah Fachiroh, Dewi Kartikawati Paramita, Septi Kurnia Lestari, Bayu Satria Wiratama, Annisa Ryan Susilaningrum, Bara Kharisma, Yogi Hasna Meisyarah, Merlinda Permata Sari et al. · 2022 · PLoS ONE
  21. Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
    S. Thasneem Banu, S.Vinotha, Radhika Katragadda, R. Vanaja · 2023 · Journal of Pure and Applied Microbiology
  22. Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility
    Nicole V. Tolan, Mia S. DeSimone, M. Fernandes, Joshua E. Lewis, D. Simmons, P. Schur, M. Brigl, M. Tanasijevic, M. Desjardins, A. Sherman et al. · 2023 · Clinical Biochemistry
  23. Clinical risk factors for predicting anti-Sars-CoV-2 antibody immunoreactivity duration after mild COVID-19 infection
    Maria da Penha Gomes Gouvea, Allan Gonçalves Henriques, Maria Eduarda Morais Hibner Amaral, Isac Ribeiro Moulaz, Jéssica Fábia Polese, Karen Evelin Monlevade Lança, Thayná Martins Gouveia, Bárbara Sthefany de Paula Lacerda, Beatriz Paoli Thompson, José Geraldo Mill et al. · 2023 · Journal of Human Growth and Development
  24. SARS-CoV-2 antibody response duration and neutralization following natural infection
    Christopher W. Dukes, R. A. M. Rossetti, Jonathan A. Hensel, Sebastian A. Snedal, Christopher L. Cubitt, Michael J. Schell, Martha E. Abrahamsen, Kimberly A. Isaacs‐Soriano, Kayoko Kennedy, Leslie N. Mangual et al. · 2023 · Journal of Clinical Virology Plus
  25. Evaluation of the Abdala Vaccine: Antibody and Cellular Response to the RBD Domain of SARS-CoV-2
    Lorenzo Islas-Vázquez, Yan Carlos Alvarado-Alvarado, Marisa Cruz‐Aguilar, Henry Velázquez-Soto, Eduardo Villalobos-Gonzalez, Gloria Ornelas-Hall, Sonia Mayra Pérez‐Tapia, María del Carmen Jiménez Martínez · 2023 · Vaccines
  26. SECCION X. Prevención y control de la infección por SARS – COV-2/COVID-19
    Carlos Humberto Saavedra Trujillo · 2021 · Infectio
  27. The prevalence of SARS-CoV-2 antibodies in triage-negative patients and staff of a fertility setting from lockdown release throughout 2020
    Corina Manolea, Andrei Căpitănescu, Roxana Georgiana BORS, Ioana Adina Rugescu, Melihan Bechir, Claudia Mehedințu, Valentin Nicolae Varlas · 2021 · Human Reproduction Open
  28. Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation
    Cara L. Staszewski, Burton L. Rochelson, David Krantz, Rachel P. Gerber, Hannah Juhel, Shreya Reddy, Matthew J. Blitz · 2021 · American Journal of Obstetrics and Gynecology
  29. Overview of the neutralizing antibody and memory B cell response kinetics in SARS-CoV-2 convalescent and/or mRNA vaccinated individuals.
    Irina Grigorova · 2021 · System Biology and Physiology Reports
  30. 12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort
    Florian Deisenhammer, Angelika Bauer, Chiara Kavelar, Dagmar Rudzki, Annika Rössler, Janine Kimpel, Wegene Borena, Markus Reindl · 2021 · Wiener klinische Wochenschrift
  31. Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
    Kelli M. Money, Ursela Baber, Emma Saart, Soleil Samaan, Jacob A. Sloane · 2022 · Frontiers in Neurology
  32. Manufacturer Signal-to-Cutoff Threshold Underestimates Cumulative Incidence of SARS-CoV-2 Infection: Evidence from the Los Angeles Firefighters Study
    Omar Toubat, Anders Hayden Berg, Kimia Sobhani, Karen Mulligan, Acacia M Hori, Jay Bhattacharya, Neeraj Sood · 2022 · The Journal of Applied Laboratory Medicine
  33. A deconvolution approach to modelling surges in COVID-19 cases and deaths
    Adam Melnyk, Lena Kozarov, Sebastian Wachsmann‐Hogiu · 2022 · Scientific Reports
  34. Population Changes in Seroprevalence among a Statewide Sample in the United States
    Kristen M. C. Malecki, Mária Nikodémová, Amy Schultz, Andrew J. Bersch, Matthew C Walsh, Ajay K. Sethi, Paul E. Peppard, Corinne D. Engelman, Lisa Cadmus‐Bertram, Nasia Safdar et al. · 2020 · medRxiv
  35. SARS-CoV-2 transmission from the healthcare setting into the home: a prospective longitudinal cohort study
    S. Craxford, Jessica Nightingale, A. Ikram, B. Marson, Anthony Kelly, Alan Norrish, Amrita Vijay, S. Astbury, Lola Cusin, Waheed Ashraf et al. · 2021 · medRxiv
  36. Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
    Narendra B. Chirmule, Pradip Nair, Bela Desai, Ravindra Khare, Vivek R. Nerurkar, Arpit Gaur · 2021 · medRxiv
  37. COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
    Athanasios‐Dimitrios Bakasis, Haralampos Μ. Moutsopoulos · 2021 · Mediterranean Journal of Rheumatology
  38. Interpretation of non-responders to SARS-CoV-2 vaccines using WHO International Standard
    Qiang Zeng, Xue Yan Yang, Qi Gao, Biaoyang Lin, Yongzhe Li, Gang Huang, Yang Xu · 2022 · medRxiv
  39. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  40. Anticuerpos Anti SARS-CoV-2, Post-vacunación en Cochabamba, Bolivia
    Jhonny Limachi-Choque, Aleida Verduguez-Orellana · 2022 · Gaceta Médica Boliviana
  41. mRNA vaccines for COVID-19
    Anamika Sengupta · 2022 · Elsevier eBooks
  42. SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study
    Ketlyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro · 2024 · Infectious Disease Reports
  43. Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months
    Qin Luo, Qinqin Song, Yan Li, Kexin Zong, Ti Liu, Junming He, Guo-yong Mei, Haijun Du, Zhiqiang Xia, Mi Liu et al. · 2025 · Frontiers in Immunology
  44. Autoantibodies in COVID-19: Pathogenic Mechanisms and Implications for Severe Illness and Post-Acute Sequelae
    Lais Alves do Nascimento, Nicolle Rakanidis Machado, Isabela Siuffi Bergamasco, João Vitor da Silva Borges, Fábio da Ressureição Sgnotto, Jefferson Russo Victor · 2025 · COVID
  45. SARS-CoV-2-specific B cell responses in non-draining lymph nodes and antibody functionalities in immunized end-stage renal disease patients
    Sophie C. Frölke, Daryl Geers, Kenney Gino Amirkhan, Danisha Sri Pathmarajah, Nelly D. van der Bom‐Baylon, Mirza M. Idu, Marit J. van Gils, Mathieu A. F. Claireaux, Suzanne E. Geerlings, Theo Rispens et al. · 2025 · Scientific Reports
  46. Long-Term Protective Immune Responses Induced by rBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron
    G. Gaboardi, M. Trentini, A. I. Kanno, Luana Moraes, A. D. Januzzi, L. R. Pereira, G. Dias, L. Huergo, Sergio C. Oliveira, A. Báfica et al. · 2026 · Vaccines
  47. Human Challenge Studies with Coronaviruses Old and New
    Richard McKendry, Nana‐Marie Lemm, Loukas Papargyris, Christopher Chiu · 2021 · Current topics in microbiology and immunology
  48. Neutralizing Antibody Responses Among Residents and Staff of Long-Term Care Facilities in the State of New Jersey During the First Wave of the COVID-19 Pandemic
    Stephen M. Friedman, Jieliang Li, Pauline Thomas, Manisha Gurumurthy, Richard H. Siderits, Anna Nepomich, Edward I. Lifshitz · 2022 · Journal of Community Health
  49. Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection
    Camila Amormino Corsini, Priscilla Soares Filgueiras, Nathalie Bonatti Franco Almeida, Daniel Alvim Pena de Miranda, Sarah VC Gomes, Adelina Junia Lourenço, Cecília MF Bicalho, Jéssica Vieira de Assis, Raquel NH Amorim, Raphael A Silva et al. · 2023 · Scientific Reports
  50. Immunological Efficacy of Vaccination against COVID-19 in Employees of Medical Institutions of Various Profiles: Psychiatric Hospital and Regional Hospital
    Alyona A. Murzina, Alexander V. Zubkov, О. А. Свитич, Alla Nikolaevna Kaira · 2024 · Epidemiology and Vaccinal Prevention
  51. Sustained natural immunity following SARS-CoV-2 infection against severe COVID-19 outcomes and symptomatic reinfection: analyses of national data for Brazil and Scotland
    Fasih Haider, Thiago Cerqueira Silva, Kirsten Hainey, Tristan Millington, Syed Ahmar Shah, Valdineia Matos de Oliveira, Neil E. Pearce, Maurício L. Barreto, Viviane Sampaio Boaventura, Srinivasa Vittal Katikireddi et al. · 2025 · BMJ Open
  52. Impact of obesity on COVID-19 CoronaVac and ChAdOx1-S vaccine efficacy
    Márcio Valle Cortez, Alex Martins, Joabi Rocha Nascimento, Fabíola Mendonça da Silva Chui, Maria Rodrigues, T. X. Bastos, Sônia Maria Lemos, Eduardo Jorge Sant’Ana Honorato, Erika Gomes, Rebeca Linhares Abreu Netto et al. · 2025 · BMC Infectious Diseases
  53. Neutralizing activity to SARS‐CoV‐2 in 1.2 to 10.0 month convalescent plasma samples of COVID‐19: A transversal surrogate in vitro study performed in Quito‐Ecuador
    Boris Hernán Villacrés Granda, Elius Paz‐Cruz, Maria Jose Miguez Burbano, Irina Villacrés‐Granda, Daniela Armijos, Guillermo Mauricio Aguirre Balseca · 2022 · Journal of Medical Virology
  54. Prevalence and risk factors of Severe Acute Respiratory Syndrome Coronavirus 2 infection in women and children in peri-urban communities in Pakistan: A prospective cohort study
    Nadia Ansari, Muhammad Imran Nisar, Farah Khalid, Usma Mehmood, Asra Usmani, Fariha Shaheen, Aneeta Hotwani, Kehkashan Begum, Amina Barkat, Sachiyo Yoshida et al. · 2022 · Journal of Global Health
  55. Association of Time-Lines of COVID-19 Seropositivity with Antibody Ratio Levels
    Saadiya Mushtaq, Nasir Ud Din, Abid Hussain Shah, Omair Riaz, Khalid Azam, Sara Waqar Khan · 2022 · Pakistan Armed Forces Medical Journal
  56. Kinetics of Anti-SARS-CoV-2 Antibody Response Following Two Doses of the BNT162b2 mRNA Vaccine: A Japanese Single-Center Primary Care Clinic Report Involving Volunteers and Patients with Autoimmune Disease
    Tomoko Sugiura, Hiroaki Sugiura, Hiroaki Kato, Yuko Nariai, Yuuki Mizumoto, Kozue Hanada, Rieko Takahashi, Yukari Hinotubo, Naoko Tanaka, Mutsumi Sasaki et al. · 2022 · Infectious Disease Reports
  57. Serology study of healthcare workers following a hospital-based outbreak of COVID-19 in North West Tasmania, Australia, 2020
    Michelle McPherson, Nicola Stephens, Kylie J. Smith, Therese Marfori, Meru Sheel, Louise Cooley, Belinda McEwan, Mark Veitch, Fay Helena Johnston · 2023 · Communicable Diseases Intelligence
  58. Association between SARS-CoV-2 anti-spike antibody titers and the development of post-COVID conditions: A retrospective observational study
    Yusuke Miyazato, Shinya Tsuzuki, Akihiro Matsunaga, Shinichiro Morioka, Mari Terada, Sho Saito, Noriko Iwamoto, Satoshi Kutsuna, Yukihito Ishizaka, Norio Ohmagari · 2023 · Global Health & Medicine
  59. Impact of Health Workers’ Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey
    Meryem Merve Ören, Sevgi Canbaz, Sevim Meşe, Ali Ağaçfidan, Ömer Faruk Demir, Esra Karaca, Ayşe Rumeysa Doğruyol, GOKCE Hazar Otcu, Tufan Tükek, Nuray Özgülnar · 2023 · Vaccines
  60. SARS-CoV-2 Reinfection Rate: A Systematic Review and Meta-analysis
    Yousef Alimohamadi, Kiana Bahani, Kolsoom Alimohamadi, Mojtaba Sepandi · 2023 · Infection Epidemiology and Microbiology
  61. COVID-19 in Kidney Transplant Recipients: What Did We Understand After Three Years Since the Pandemic Outbreak in Kidney Transplant Recipients?
    A. Canossi, Alessandra Panarese, Valentina Savino, Tiziana Del Beato, Francesco Pisani · 2023 · Current Transplantation Reports
  62. Comparative IgG Antibody Titers Following Second Dose of Sinopharm and Pfizer Vaccination
    Hira Tanveer, Sehrish Zaffar, Muhammad Osama, Isma Ishaq, Javaria Arshad Malik, Rabiea Bilal, Afnan Talat, Aisha Talat · 2023 · BIOMEDICA
  63. Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico
    Yanet Ventura-Enríquez, Evelyn Cortina-De la Rosa, Elizabeth Díaz-Padilla, Sandra Murrieta, Silvia Segundo-Martínez, Verónica Fernández-Sánchez, Cruz Vargas‐De‐León · 2024 · Viruses
  64. Single-particle rotational sensing for analyzing the neutralization activity of antiviral antibodies
    Jinhui Shang, Huiwen Li, Xixuan Liu, Shijie Sun, Shuangyan Huan, Bin Xiong · 2024 · Talanta
  65. Detection of HIV ‐1 Antibodies in Saliva of Persons Living With HIV Using Blood‐Based First Response HIV 1‐2.O Card Test
    Enoch Aninagyei, Comfort Addo Boatey, Gifty Larbi, Wilson Bright Tsidi, Raphael Eyram Amemo, Ebenezer Tawiah Nyarkotey, Godknows Afenya, Desmond Omane Acheampong · 2025 · Journal of Clinical Laboratory Analysis
  66. Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company
    Petra Moroni-Zentgraf, Christoph Keller, Mazyar Mahmoudi, Kimberley Kallsen, Christoph Cyrill Eschenfelder, Ralf Sigmund, Hanns Walter Müller, Patrick Baum, Bertram Boos, Michael Schneider et al. · 2021 · Current Medical Research and Opinion
  67. Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes
    Harald Willschke, Thomas Wochele‐Thoma, Atanas G. Atanasov, Elisabeth Klager, Christian Haslinger, Maria Kletečka-Pulker, Daniel Laxar, Care Ay, Thomas Öhlinger, Oliver Kimberger et al. · 2021 · Aging and Disease
  68. A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era
    Sean C. Taylor · 2021 · Journal of Clinical Virology Plus
  69. High class filtering facepiece (FFP) are fundamental and effective in protection of emergency health care workers: an observational cohort study in a German community
    Martin Lier, Stefan Nessler, Christine Stadelmann, Meike Pressler, Leif Saager, Onnen Moerer, Markus Roeßler, Konrad Meissner, Martin Sebastian Winkler · 2021 · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine
  70. An immunological autobiography: my year as a COVID-19 vaccine trial participant
    Ross M. Kedl · 2022 · npj Vaccines
  71. 19. Einsatz gentechnologischer Methoden in der Impfstoffentwicklung gegen das SARS-CoV-2-Virus
    Martin Körte · 2021 · Nomos Verlagsgesellschaft mbH & Co. KG eBooks
  72. Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections
    Ikuro Matsuba, Tetsuo Takuma, Nobuo Hatori, Masahiko Takai, Yoshiyuki Watanabe, Nobukazu Takada, Satoru Kishi, Yoko Matsuzawa, Tetsuo Nishikawa, Tomoyuki Kunishima et al. · 2021 · Internal Medicine
  73. Seroprevalence of COVID-19 IgG Antibody in Resident and Fellow Physicians in Milwaukee, Wisconsin: Analysis of a Cross-Sectional Survey
    Dennis J Baumgardner, A Schwank, Jessica J.F. Kram, Wilhelm Lehmann, Jacob Bidwell, Tricia La Fratta, Kenneth Copeland · 2022 · Journal of patient-centered research and reviews
  74. Viral shedding and the durability of immunoglobulin G antibodies to severe acute respiratory syndrome coronavirus 2
    Maria Inge Lusida, Emily Gunawan, Ni Luh Ayu Megasari, Laura Navika Yamani, Juniastuti Juniastuti, Takako Utsumi, Yasuko Mori · 2022 · Microbiology and Immunology
  75. SARS-CoV-2 RT-PCR Pozitif Sağlık Çalışanlarında Serokonversiyon Durumunun Boylamsal İzlenmesi
    Leyla Ersoy, Seda Tezcan Ülger, Harun GÜLBUDAK, Nurbanu Yaşar, Gülçin Yapıcı, Gönül Aslan · 2022 · Mikrobiyoloji Bulteni
  76. Anti-viral memory T cell responses in the absence of IgG production in a COVID-19 convalescent individual
    Ling Ni, Fang Ye, Qin Qiao, Feng Yu, Yazheng Yang, Hui John Zhao, Li-nan Zhang, Meng‐Li Cheng, Gengzhen Zhu, Xiaoli Li et al. · 2022 · National Science Open
  77. Comparison of First and 21st Day anti SARS-CoV-2 anti-spike IgM and IgG Responses
    Muhammed Emin Düz, Aydın Balcı, Elif Berber Menekse, Mustafa Durmaz, Alper Gümüş · 2022 · Turkish Journal of Immunology
  78. Sağlık Çalışanları SARS-CoV-2 Hasta Kohordunda Antikor Sürdürülebilirliği
    Erhan Eser, Şebnem Şenol Akar, Sinem Akçalı, Talat Ecemiş, Pınar Erbay Dündar, Kübra Çiçek, Damla Akman, Ecem Tüzün, Gülsüm ŞANLI ERKEKOĞLU, Zeynep Ceyda Buran et al. · 2022 · Mikrobiyoloji Bulteni
  79. Serological follow up of positive SARS-CoV-2 cases
    José Gerardo González‐González, Adrián Camacho-Ortíz, René Rodríguez‐Gutiérrez, Donato Saldívar‐Rodríguez, Luz Adriana Ramírez-García, Adriana Sánchez‐García · 2022 · Salud Pública de México
  80. Antibody- and T Cell-Dependent Responses Elicited by a SARS-CoV-2 Adenoviral-Based Vaccine in a Socially Vulnerable Cohort of Elderly Individuals
    M. Martínez Moya, Marcela Marrama, Carina Dorazio, Florencia Veigas, Montana N Manselle Cocco, Tomás Dalotto‐Moreno, Gabriel A. Rabinovich, Ariel Aleksandroff · 2022 · Vaccines
  81. SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran
    Aida Amanat, Kamran Bagheri Lankarani, Behnam Honarvar, Naeimehossadat Asmarian, Mansoureh Shokripour, Fatemeh Rafiee, Mir Behrad Aghazadeh Ghadim, Farahnaz Izadi, Navid Omidifar, Seyed Abolfazl Dorraninejad · 2022 · Shiraz E-Medical Journal
  82. A Pilot Study to Examine If Dietary Habits Can Affect Symptomology in Mild Pre-Vaccination COVID-19 Cases
    Kaine Moreno McDaid, Mridula Chopra · 2022 · Biology
  83. Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region
    Stacia M. DeSantis, Luis León‐Novelo, Michael D. Swartz, Ashraf S. Yaseen, Melissa A. Valerio-Shewmaker, Yashar Talebi, Frances A. Brito, Jessica A. Ross, Harold Willis Kohl, Sarah Elizabeth Messiah et al. · 2022 · PLoS ONE
  84. Rates of Asymptomatic COVID-19 Infection and Associated Factors in Olmsted County, Minnesota, in the Prevaccination Era
    Celine M. Vachon, Aaron D. Norman, Kavita Prasad, Dan Jensen, Gavin M. Schaeferle, Kristy L. Vierling, Meaghan Sherden, Michelle R. Majerus, Katherine A. Bews, Ethan P. Heinzen et al. · 2022 · Mayo Clinic Proceedings Innovations Quality & Outcomes
  85. A Case Series of SARS-CoV-2 Reinfection in Elite Athletes
    G. Fülöp, B. Lakatos, M. Ruppert, A. Kovács, V. Juhász, G. Dér, A. Tállay, H. Vágó, B. Kiss, B. Merkely et al. · 2022 · International Journal of Environmental Research and Public Health
  86. Some Doubts Vaccine Boosters, Vaccine Passports, and Prohibition to Use Antivirals Help with Cases and Fatalities of COVID-19 Infection
    Alberto A. Boretti · 2022 · Indian Journal of Otolaryngology and Head & Neck Surgery
  87. An epidemiological and retrospective study in a cohort qualified for SARS-CoV-2 vaccination in the region of Lower Silesia, Poland
    Monika Stępień, Natalia Świątoniowska-Lonc, Brygida Knysz, Beata Jankowska‐Polańska, Amadeusz Kuźniarski, Agnieszka Piwowar, Małgorzata Zalewska · 2023 · Advances in Clinical and Experimental Medicine
  88. Global epidemiology and impact of the SARS-CoV-2 pandemic
    Sofía Bernal‐Silva, Angélica Torres‐Díaz, Andreu Comas‐García · 2023 · Elsevier eBooks
  89. Unilateral Axillary Lymphadenopathy in Cancer Patients Post-COVID-19 Vaccination: Review and Case Series
    Sumaya Hasan Zoughbor, Zakeya Al Rasbi, Ali Yousif, Mouza Al Ameri, Mawada Mohamed Hussein, Mohammad Saeed Hourani, Shima Mohamed Khamis, Hidayath Ansari, Iram Syed, Khalid S Balaraj et al. · 2023 · Case Reports in Oncology
  90. Immunological survey of COVID-19 among medicos of tribal preponderant state of India
    Sushma Kumari, K Jeseena, Asha K. Kiran, Manisha Kujur, Usha Saroj, Shailesh Sanjul Hembrom, Anit Kujur · 2023 · Journal of Family Medicine and Primary Care
  91. IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
    Huan Xie, Jing Zhang, Ran Luo, Yan Qi, Yizhang Lin, Changhao Han, Xi Li, Dongfeng Zeng · 2024 · BMC Immunology
  92. Integrated antibody language model accelerates IgG screening and design for broad-spectrum antiviral therapy
    Hannah Faisal Almubarak, Wuwei Tan, Andrew Daniel Hoffmann, Yuanfei Sun, Juncheng Wei, Lamiaa El-Shennawy, Joshua R Squires, Nurmaa Khund Dashzeveg, Brooke Simonton, Yuzhi Jia et al. · 2025 · iScience
  93. High exposure of pregnant women to SARS-CoV-2 during COVID-19 waves in Senegal
    Abou Abdallah Malick Diouara, Fatou Thiam, Seynabou Coundoul, Noel Magloire Manga, Halimatou Diop‐Ndiaye, Assane Senghor, Sophie Déli Tene, Sarbanding Sané, Betty Kane, Habibou Sarr et al. · 2026 · BMC Pregnancy and Childbirth
  94. Modelling COVID-19 evolution in Italy with an augmented SIRD model using open data
    Vincenzo Nardelli, Giuseppe Arbia, Andrea Palladino, Atzeni Lg · 2021 · medRxiv
  95. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  96. Molecular and Serologic Diagnostic Technologies for SARS-CoV-2
    Halie M. Rando, Christian Brueffer, Ronan Lordan, Anna Ada Dattoli, David Manheim, Jesse G. Meyer, Ariel I. Mundo, Dimitri Perrin, David Mai, Nils Wellhausen et al. · 2022 · PubMed
  97. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv
  98. Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
    Carlota Dobaño, Anna Ramirez, Selena Alonso, Josep Vidal‐Alaball, Gemma Ruiz‐Olalla, Marta Vidal, Rocío Rubio, Emma Cascant, Daniel Parras, Natalia Rodrigo Melero et al. · 2021 · Research Square
  99. WITHDRAWN
    Shoumen Datta · 2020 · ChemRxiv
  100. WITHDRAWN
    Shoumen Datta · 2021 · ChemRxiv